Atturos Host Clinical and Technical Brainstorming Session with Key Opinion Leaders

Last Friday May 13th Atturos hosted a Clinical and Technical Brainstorming session in NovaUCD as part of our market analysis to obtain and evaluate customer and end user attitudes towards the OCProDx test. The workshop brought together key opinion leaders from industry and academia, and the information gathered will help shape our development over the next 18 months.

Support from Enterprise Ireland and Horizon 2020 gave Atturos the opportunity to host the Brainstorming “Think Tank” which brought together some top talents from industry and academia. Dorman Followwill, Partner and Director of Europe, Israel & Africa at consulting and market research firm Frost & Sullivan, was the master of ceremonies for the event, and helped to create a positive environment for attendees to share their ideas and insights. Patient advocates Tom Hope and John Dowling gave unique and fundamental insights into the process of prostate cancer diagnosis.

Technical experts included Anthony Sullivan of Agilent and Director of International Scientific Support at Meso Scale Discovery Chris Walker. The morning session covered topics including the use of mass spectrometry, the assay’s technical performance, and regulatory issues. The clinical workshop took place in the afternoon and dealt with issues including current standards of treatment, the influence of OCProDx on patient outcomes, and clinical evaluation studies. Maria Fitzgibbon and Marguerite McMahon, Head of the Department of Clinical Chemistry and Principal Biochemist in the Mater University Hospital respectively, spoke about how new molecular and diagnostic tests enter clinician workflows and gave insight into the day-to-day workings of clinical hospital laboratories. Professor Richard Ablin, the scientist who discovered PSA, was also in attendance at brainstorming sessions. Professor Ablin also gave a public talk in the UCD Conway Institute about his career and the use (and misuse) of PSA as a screening tool for prostate cancer.

On May 27th the final brainstorming session will focus on business development and will cover the topics of routes to market, product positioning, potential risks and financial planning. Sally Price of BioHub at Alderly Park and Laboratory Director of Biomnis Ireland Michael Louw are due to attend.